Valuation: Asahi Kasei Corporation

Market Cap 1,964B 12.37B 11.27B 10.38B 9.45B 17.72B 1,146B 18.62B 126B 50.23B 626B 46.42B 45.45B P/E 2027 *
11.1x
P/E 2028 * 10.6x
Enterprise Value 2,633B 16.59B 15.11B 13.92B 12.66B 23.76B 1,536B 24.97B 169B 67.34B 839B 62.24B 60.93B EV / Sales 2027 *
0.78x
EV / Sales 2028 * 0.76x
Free-Float
95.42%
Yield 2027 *
3.12%
Yield 2028 * 3.52%
11-13 Asahi Kasei Homes Launches 12.88 Billion Yen Tender Offer for Mori-Gumi MT
11-12 Asahi Kasei, Circularise, And Furuya Metal Launch Demonstration Project For Precious Metal Traceability In Chlor-Alkali Electrolysis Electrodes CI
11-05 Asahi Kasei Posts Higher Fiscal H1 Attributable Income; Revenue Up MT
11-05 Asahi Kasei Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2027 CI
11-05 Asahi Kasei Corporation Announces Dividend for the Second Quarter End of Fiscal Year Ending March 31, 2027, Payable on December 1, 2026; Revises Dividend Guidance for the Full Fiscal Year Ending March 31, 2027 CI
11-05 Asahi Kasei Corporation Reports Earnings Results for the Half Year Ended September 30, 2026 CI
11-04 Asahi Kasei Signs Memorandum of Understanding with Power to Hydrogen to Accelerate Commercialization of Anion Exchange Membrane Water Electrolysis for Clean Hydrogen Production CI
10-23 Asahi Kasei Pins Its Growth on Electronic Materials Zonebourse
10-10 Asahi Kasei Therapeutics, Inc. Announces FDA Approval Of HOVILPRI Tablets Developed By AiCuris Anti-Infective Cures AG For Mucocutaneous HSV Lesions Refractory To Standard Antiviral Treatment In Immunocompromised Adults CI
10-09 US FDA approves Asahi Kasei's drug for persistent herpes infections RE
10-09 Japan's Nikkei limps to weekly loss as AI doubts, bond stress weigh RE
10-08 Asahi Kasei Therapeutics Announces First Patient Dosed in Phase 2a Trial of AIC468 for BK Virus Infection in Kidney Transplant Recipients CI
10-01 Teijin Frontier, Asahi Kasei Advance Merge to Form TA Frontier MT
1 day-4.29%
1 week-9.69%
Current month-8.23%
1 month-7.10%
3 months-9.88%
6 months-12.01%
Current year+6.01%
1 week 1,472.5
Extreme 1472.5
1,642.5
1 month 1,472.5
Extreme 1472.5
1,660
Current year 1,415
Extreme 1415
1,906
1 year 1,247
Extreme 1247
1,906
3 years 880
Extreme 880
1,906
5 years 880
Extreme 880
1,906
10 years 606.1
Extreme 606.1
1,906
Manager TitleAgeSince
Director of Finance/CFO - -
President 67 31/03/2022
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 71 31/03/2022
Director/Board Member 79 31/05/2018
Director/Board Member 67 31/05/2021
Change 5-day change 1-year change 3-year change Capi.($)
-4.29%-9.69%+13.31%+46.23% 12.37B
-5.28%-8.19%+18.11%+1.49% 59.91B
-2.60%-9.05%+15.41%+11.66% 46.66B
+2.50%+6.18%+8.80%+30.46% 17.82B
-2.99%-4.77%+16.67%-27.19% 8.86B
-4.28%-8.95%+18.04%+3.32% 8.46B
-2.22%-5.43%+11.13% - 8.39B
-0.15%+1.38%-12.02%+7.74% 8.03B
-0.97%-16.45%+66.68%-9.65% 7.36B
+0.29%+1.05%+2.33%-4.18% 5.71B
Average -2.00%-5.35%+15.85%+6.65% 18B
Weighted average by Cap. -2.91%-6.47%+15.94%+8.58%

Financials

2027 *2028 *
Net sales 3,370B 21.23B 19.34B 17.82B 16.21B 30.41B 1,966B 31.96B 217B 86.19B 1,074B 79.66B 77.98B 3,407B 21.46B 19.55B 18.01B 16.38B 30.74B 1,987B 32.3B 219B 87.13B 1,086B 80.53B 78.83B
Net income 179B 1.13B 1.03B 945M 860M 1.61B 104B 1.69B 11.5B 4.57B 56.95B 4.22B 4.14B 186B 1.17B 1.07B 983M 894M 1.68B 108B 1.76B 11.96B 4.75B 59.21B 4.39B 4.3B
Net Debt 669B 4.22B 3.84B 3.54B 3.22B 6.04B 390B 6.34B 43.06B 17.11B 213B 15.82B 15.48B 619B 3.9B 3.55B 3.27B 2.97B 5.58B 361B 5.86B 39.8B 15.82B 197B 14.62B 14.31B
Projected Income Statement - Annual - Asahi Kasei Corporation
Logo Asahi Kasei Corporation
Asahi Kasei Corp is a Japan-based company mainly engaged in the materials business, housing business and healthcare business. The Company operates through three business segments. The Materials segment provides styrene monomer, acrylonitrile, polyethylene, automotive-related fibers, electronic materials, mixed signal large scale integrated circuits (LSI), hall elements, deep ultraviolet light-emitting diodes (LEDs), pharmaceutical and food additives and others. The Housing segment provides construction contracting, renovation and other housing-related business, as well as lightweight aerated concrete (ALC), insulation materials and others. The Healthcare segment provides medical drugs, hemodialysis and apheresis related equipment, virus removal filters, cardiopulmonary resuscitation-related products and others. The Company also provides plant engineering, environmental engineering, various research and information provision businesses, and personnel dispatch and introduction services.
Employees
47,895
Date Price Change Volume
20/11/26 JP¥1,472.50 -4.29% 5,473,800
19/11/26 JP¥1,538.50 -1.00% 3,713,900
18/11/26 JP¥1,554.00 -1.99% 4,662,300
17/11/26 JP¥1,585.50 -1.28% 3,467,100
16/11/26 JP¥1,606.00 -1.50% 3,017,700
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - Asahi Kasei Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
1,472.50JPY
Average target price
1,948.18JPY
Spread / Average Target
+32.30%
  1. Stock Market
  2. Stocks
  3. 3407 Stock